BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 31666296)

  • 21. Phages Needed against Resistant Bacteria.
    Moelling K
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32664292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage Therapy Approaches to Reducing Pathogen Persistence and Transmission in Animal Production Environments: Opportunities and Challenges.
    Colavecchio A; Goodridge LD
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28664828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phages & antibiotic resistance: are the most abundant entities on earth ready for a comeback?
    Hill C; Mills S; Ross RP
    Future Microbiol; 2018 May; 13():711-726. PubMed ID: 29792526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phage therapy efficacy: a review of the last 10 years of preclinical studies.
    Melo LDR; Oliveira H; Pires DP; Dabrowska K; Azeredo J
    Crit Rev Microbiol; 2020 Feb; 46(1):78-99. PubMed ID: 32091280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophages and its applications: an overview.
    Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
    Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Creation of synthetic bacterial viruses].
    Ando H
    Nihon Saikingaku Zasshi; 2018; 73(4):201-210. PubMed ID: 30487377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
    Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
    Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
    Kim BO; Kim ES; Yoo YJ; Bae HW; Chung IY; Cho YH
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
    Mangalea MR; Duerkop BA
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phage Therapy: Various Perspectives on How to Improve the Art.
    Abedon ST
    Methods Mol Biol; 2018; 1734():113-127. PubMed ID: 29288451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phage therapy of wound-associated infections.
    Zyman A; Górski A; Międzybrodzki R
    Folia Microbiol (Praha); 2022 Apr; 67(2):193-201. PubMed ID: 35028881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
    Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
    Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally-occurring and cultured bacteriophages in human therapy.
    Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of phage-mediated biocontrol of bacteria.
    Abedon ST
    Foodborne Pathog Dis; 2009 Sep; 6(7):807-15. PubMed ID: 19459758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The forgotten tale of Brazilian phage therapy.
    Almeida GMF; Sundberg LR
    Lancet Infect Dis; 2020 May; 20(5):e90-e101. PubMed ID: 32213334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens.
    Manohar P; Loh B; Elangovan N; Loganathan A; Nachimuthu R; Leptihn S
    Microbiol Spectr; 2022 Feb; 10(1):e0139321. PubMed ID: 35171008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.